首页> 外文OA文献 >Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma–a Single Institute Analysis of 10 Cases

【2h】

Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma–a Single Institute Analysis of 10 Cases

机译：同种异体干细胞移植治疗复发性和难治性多发性骨髓瘤-单例分析10例

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ikeda Masahiro; Tsukada Nobuhiro; Shingaki Sumito; Miyazaki Kanji; Meshitsuka Sosuke; Yoshiki Yumiko; Abe Yu; Suzuki Kenshi;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma-a Single Institute Analysis of 10 Cases [J] . Ikeda Masahiro, Tsukada Nobuhiro, Shingaki Sumito, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：同种异体干细胞移植治疗复发性和难治性多发性骨髓瘤-单例分析10例
2. Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma: a single institute experience. [J] . Kuroda J, Kobayashi T, Tsutsumi Y, International journal of hematology . 2010,第4期

机译：硼替佐米用于多发性骨髓瘤的异基因造血干细胞移植后复发和GVHD：一次研究的经验。
3. Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma: a single institute experience [J] . Junya Kuroda, Tsutomu Kobayashi, Yasuhiko Tsutsumi, International Journal of Hematology . 2010,第4期

机译：硼替佐米用于多发性骨髓瘤的异基因造血后干细胞移植复发和GVHD：单一机构的经验
4. SmartTransplantation - Allogeneic Stem Cell Transplantation as a Model for a Medical Expert System [C] . Gerrit Meixner, Nancy Thiels, Ulrike Klein Symposium of the Workshop on Human-Computer Interaction and Usability Engineering of the Austrian Computer Society(USAB 2007); 20071122; Graz(AT) . 2007

机译：SmartTransplantation-同种异体干细胞移植作为医学专家系统的模型
5. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
6. Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? [O] . Hyunkyung Park, Ja Min Byun, Sung-Soo Yoon, 2020

机译：异种干细胞移植复发/难治性多发性骨髓瘤治疗：它仍然是相关的吗？
7. Allogeneic Hematopoietic Stem Cell Transplantation With Reduced-Intensity Conditioning In Patients With Refractory And Relapsing Multiple Myeloma: Long-Term Follow-Up [O] . Shimoni A., Hardan I., Ayuk F., 2010

机译：难治性和复发性多发性骨髓瘤患者同种异体造血干细胞移植的低强度条件治疗：长期随访

Allogeneic Stem Cell Transplantation for Relapsed and Refractory Multiple Myeloma–a Single Institute Analysis of 10 Cases

著录项

引文网络

相似文献

相关主题

期刊订阅